The results of the studies indicate that the third dose of the COVID-19 vaccine reduces the risk of re-infection by 11 times and the development of complications in people over the age of 60 by 19 times, said Yagut Garayeva, head of the department of Azerbaijan’s Union for Management of Medic al Territorial Units (TABIB).
Story developing
More about: